title: Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: A pilot study.
authors.affiliation: Department of Dermatology, Venereology and Leprosy, Government Medical College and Associated Hospitals, Jammu, Jammu and Kashmir, India.
authors.forename: Devraj
authors.initials: D
authors.lastname: Dogra
authors.forename: Naina Kala
authors.initials: NK
authors.lastname: Dogra
authors.forename: Nishu
authors.initials: N
authors.lastname: Gupta
authors.forename: Vipin
authors.initials: V
authors.lastname: Gupta
mesh_terms: D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D002648:Child; D003907:Dexamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010392:Pemphigus / Q000188:drug therapy*; D010431:Pentoxifylline / Q000008:administration & dosage*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010865:Pilot Projects; D012074:Remission Induction / Q000379:methods; D012720:Severity of Illness Index; D012460:Sulfasalazine / Q000008:administration & dosage*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D012460:Sulfasalazine; D003907:Dexamethasone; D010431:Pentoxifylline